RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC. Zhang W, Wang J, Liang J, He Z, et al. Br J Cancer 2025;132:569-579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Wang J, Liang J, He Z, et al. RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC. Br J Cancer 2025;132:569-579.
PMID: 39900985